Skip to main content
Premium Trial:

Request an Annual Quote

University of Miami Gets $5M Grant to Create Genetic Diagnostics Laboratory

NEW YORK, Dec. 2 (GenomeWeb News) - The University of Miami School of Medicine will create a "comprehensive" medical genetics diagnostic laboratory with a $5 million grant from the Dr. John T. Macdonald Foundation, UM said today in a statement.

 

"This lab will be handling the [screening] tests for a newly required Floridaprogram," said Kelly Kaufhold, a spokesperson for the UM School of Medicine.

 

The Miami GeneCure Diagnostics laboratory will consist of a molecular genetics lab that will perform genetic diagnostic testing for human disease susceptibility, and a cytogenetics lab that will focus on chromosomal abnormalities, said UM. GeneCure also includes a biochemical genetic lab focused on "diagnosing and following" inborn errors of metabolism, the university said.

 

The new lab will be comprise UM's Department of Pediatrics' Molecular and Biomedical Genetics Laboratories and its cytogenics laboratory.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.